Australian Prescriber

Australian Prescriber Australian Prescriber is an independent peer-reviewed journal and podcast providing critical commentary on drugs and therapeutics for health professionals.

🚨Don’t miss out on claiming your CPD! Most health professionals can self-report CPD through their college or institution...
18/09/2025

🚨Don’t miss out on claiming your CPD!
Most health professionals can self-report CPD through their college or institution, and with some CPD deadlines approaching, now’s the perfect time to log your learning.

📚 Read the latest issue
🎧 Catch up on our podcasts
✅ Self-report your CPD before your deadline

Visit Australian Prescriber now! https://bit.ly/4nuqO9C

15/09/2025

💊 Which medicines could be risky for older patients?
Justin Coleman and Alex Choo explore the new Australian list, highlighting key drug classes such as antidepressants, , and , and how it can support safer prescribing. Listen now: https://bit.ly/4mcI3eL

The August issue of Australian Prescriber features 2 new medicines: , primary myelofibrosis, post-polycythaemia vera my...
04/09/2025

The August issue of Australian Prescriber features 2 new medicines: , primary myelofibrosis, post-polycythaemia vera myelofibrosis or post-essential thrombocythaemia . And , a new orally administered RET kinase inhibitor for treatment of RET fusion-positive non-small cell lung cancer, clinical trials have demonstrated rapid and durable responses, including intracranial activity. 👉 Explore our commentary on new drugs: https://bit.ly/4g0xTfK

🚨 New resources now available! Two new resources have been published that summarise tools that help health professionals...
02/09/2025

🚨 New resources now available! Two new resources have been published that summarise tools that help health professionals to support medicine management in people with multimorbidity and polypharmacy. With an ageing population and increasing rates of multimorbidity, polypharmacy has become a common part of the landscape. Explore the article https://bit.ly/3Vhq4IT and elevate your practice!

01/09/2025

💇‍♀️💇‍♂️ How should male and female pattern hair loss be managed?
In the latest podcast, Dhineli Perera speaks with Laxmi Iyengar and Jane Li about diagnosis, treatment options, and prescribing considerations. 🎧 Listen now: https://bit.ly/3HM4Q2G

COX-2 selective , such as celecoxib, are an effective alternative to non-selective NSAIDs for managing dental pain in p...
31/08/2025

COX-2 selective , such as celecoxib, are an effective alternative to non-selective NSAIDs for managing dental pain in people at risk of gastrointestinal toxicity and bleeding. Read this article to find out who might benefit from these drugs, including current recommendations around drug choice in dentistry➡️ https://bit.ly/4mOKtkq

-inflammatory

💡The Editorial Advisory Committee came together last week for a 2-day strategy session. Learn more about the committee...
27/08/2025

💡The Editorial Advisory Committee came together last week for a 2-day strategy session. Learn more about the committee 👉 https://bit.ly/4oGTq11 💜🎂Over the last 5 decades there has been much growth and change but our purpose remains the same and we are committed to helping health professionals make informed choices when prescribing. Here's to of Australian Prescriber. 🎉

There are many (nonsteroidal anti-inflammatory drugs) available in Australia. Choosing an NSAID for can be challengi...
25/08/2025

There are many (nonsteroidal anti-inflammatory drugs) available in Australia. Choosing an NSAID for can be challenging. Learn about the key considerations when choosing an NSAID for pain in this article➡️ https://bit.ly/3J9XvdU.

Did you know updated Australian guidelines on the use of parenteral (gentamicin, tobramycin and amikacin) have been pu...
24/08/2025

Did you know updated Australian guidelines on the use of parenteral (gentamicin, tobramycin and amikacin) have been published? These include new guidance on optimal dosing and monitoring.
Explore the full article: ➡ https://bit.ly/46SUOqT.

As the global population ages, the incidence of multimorbidity, currently estimated to be 61.9% in people aged 65 years ...
19/08/2025

As the global population ages, the incidence of multimorbidity, currently estimated to be 61.9% in people aged 65 years and over, will continue to rise. Older people using multiple medicines are at increased risk of adverse medication events. Consensus-based lists of potentially inappropriate medicines (PIMs) highlight medicines where evidence or expert consensus suggests that the potential risks usually outweigh the clinical benefits. Examples include the Beers Criteria and the STOPP tool. An Australian PIMs list was published in 2024. ➡️ https://bit.ly/4lq3dWt

18/08/2025

💊How are medicines used to treat opioid dependence? , Justin Coleman speaks with Chief Addiction Medicine Specialist for NSW, Hester Wilson, and pharmacist Jillian Kanck about diagnosing opioid dependence and the place of sublingual buprenorphine and in the treatment of opioid dependence.
Tap to listen🎧 https://bit.ly/3V4OLrT
Credits: 🎥 features Dr Laura Beaton, one of our talented Australian Prescriber Podcast hosts.

17/08/2025

Up to two-thirds of errors with blood tests occur before the sample reaches the laboratory. This article explores the factors that can affect laboratory test results, including fasting status, medications, other interfering agents, collection timing, posture and sample contamination.➡️https://bit.ly/41udd9P

Address

133 Abbotsford Street, North
Melbourne, VIC
3051

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+611800061260

Website

Alerts

Be the first to know and let us send you an email when Australian Prescriber posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Australian Prescriber:

Shortcuts

Share

Category